[yorkieusa]

This part is interesting. It sounds like they are going to get every penny out of it while they can.

A study published recently in Veterinary Dermatology suggests ProMeris “has the potential of triggering a variant of PF (pemphigus foliaceus).” But Pfizer officials aren’t acknowledging a connection between the study and its decision to discontinue the product line.

“There is no response to that article at this point,” Donner says. “I think it’s under review.”

Pfizer began notifying veterinarians about the discontinuation of both the canine and feline formulations of ProMeris this month, but Donner says the company will fulfill current orders while supplies last, or until Sept. 20.